Clinical trial

COSMO Post Approval Registry: Corox OTW Steroid LV Lead Monitoring

NCT00396136 · Biotronik, Inc., Industry · Completed

Key facts

NCT number NCT00396136
Title COSMO Post Approval Registry: Corox OTW Steroid LV Lead Monitoring
Official title Corox OTW Steroid LV Lead Monitoring
Lead sponsor Biotronik, Inc., Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Congestive Heart Failure
Intervention type Device
Interventions Corox OTW Steroid Left Ventricular Lead
Enrollment 221
Start date Oct 1, 2006
Primary completion Dec 1, 2011
Completion Dec 1, 2011
First posted Nov 6, 2006
Last update posted May 28, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies